Child Obesity

Metabolic Diseases
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Long-term Follow-up on Childhood Adiposity - The FitKids StudyN/A1 trial
Active Trials
NCT05570396Unknown178Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Novo NordiskLong-term Follow-up on Childhood Adiposity - The FitKids Study

Clinical Trials (1)

Total enrollment: 178 patients across 1 trials

NCT05570396Novo NordiskLong-term Follow-up on Childhood Adiposity - The FitKids Study

Long-term Follow-up on Childhood Adiposity - The FitKids Study

Start: Oct 2022Est. completion: Mar 2024178 patients
N/AUnknown

Related Jobs in Metabolic Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space